BRAF(V600E) mutation is a negative prognosticator in pediatric ganglioglioma (Q46190389)

20 December 2017

title

BRAF(V600E) mutation is a negative prognosticator in pediatric ganglioglioma (English)

1 reference

20 December 2017

author name string

Sonika Dahiya

1

1 reference

20 December 2017

Devon H Haydon

2

1 reference

20 December 2017

David Alvarado

3

1 reference

20 December 2017

Christina A Gurnett

4

1 reference

20 December 2017

David H Gutmann

5

1 reference

20 December 2017

Jeffrey R Leonard

6

1 reference

20 December 2017

publication date

23 April 2013

1 reference

20 December 2017

published in

Acta Neuropathologica

1 reference

20 December 2017

volume

125

1 reference

20 December 2017

issue

6

1 reference

20 December 2017

page(s)

901-910

1 reference

20 December 2017

Frequent gains at chromosome 7q34 involving BRAF in pilocytic astrocytoma

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1120-Y

Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1120-Y

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1120-Y

Mixed neuronal-glial tumors (gangliogliomas) in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1120-Y

Influence of an oligodendroglial component on the survival of patients with anaplastic astrocytomas: a report of Radiation Therapy Oncology Group 83-02.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1120-Y

Activating mutations in BRAF characterize a spectrum of pediatric low-grade gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1120-Y

Predictors of tumor progression among children with gangliogliomas. Clinical article

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1120-Y

Ganglioglioma: 13 years of experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1120-Y

Gone FISHing: clinical lessons learned in brain tumor molecular diagnostics over the last decade

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1120-Y

Clinical outcome of pediatric gangliogliomas: ninety-nine cases over 20 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1120-Y

Tandem duplication producing a novel oncogenic BRAF fusion gene defines the majority of pilocytic astrocytomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1120-Y

Adult grade II diffuse astrocytomas are genetically distinct from and more aggressive than their paediatric counterparts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1120-Y

Childhood ganglioglioma and medically intractable epilepsy. A clinicopathological study of 15 patients and a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1120-Y

Supratentorial low-grade glioma in adults: an analysis of prognostic factors and timing of radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1120-Y

Immunohistochemistry is highly sensitive and specific for the detection of V600E BRAF mutation in melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1120-Y

The 2007 WHO classification of tumours of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1120-Y

Supratentorial gangliogliomas: histopathologic grading and tumor recurrence in 184 patients with a median follow-up of 8 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1120-Y

Response criteria for phase II studies of supratentorial malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1120-Y

Tumor recurrence and malignant progression of gangliogliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1120-Y

Pediatric epileptogenic gangliogliomas: seizure outcome and surgical results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1120-Y

BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1120-Y

IDH1 mutations are common in malignant gliomas arising in adolescents: a report from the Children's Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1120-Y

Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1120-Y

Gangliogliomas in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1120-Y

Cerebral gangliogliomas during childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1120-Y

CD8+ T-cell infiltrate in newly diagnosed glioblastoma is associated with long-term survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1120-Y

Alterations of BRAF and HIPK2 loci predominate in sporadic pilocytic astrocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1120-Y

10.1007/S00401-013-1120-Y

21 January 2018

Identifiers

DOI

1 reference

20 December 2017

release_bvswf3kudffdzayms4e6l47n7u

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/bvswf3kudffdzayms4e6l47n7u

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

20 December 2017